Absence of tmRNA Has a Protective Effect against Fluoroquinolones in Streptococcus pneumoniae by Brito, Liliana et al.
fmicb-07-02164 January 7, 2017 Time: 14:56 # 1
ORIGINAL RESEARCH
published: 10 January 2017
doi: 10.3389/fmicb.2016.02164
Edited by:
Yuji Morita,
Aichi Gakuin University, Japan
Reviewed by:
Kenneth C. Keiler,
Pennsylvania State University, USA
Reynald Gillet,
University of Rennes 1, France
Andrea M. Mitchell,
University of Birmingham, UK
*Correspondence:
Mónica Amblar
mamblar@isciii.es
Adela G. de la Campa
agcampa@isciii.es
†Present address:
Joana Wilton,
Gene Regulation/Microenvironments
for New Therapies Lab, Instituto de
Investigação e Inovação em Saúde,
Universidade do Porto, Porto,
Portugal
Specialty section:
This article was submitted to
Antimicrobials, Resistance
and Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 03 November 2016
Accepted: 23 December 2016
Published: 10 January 2017
Citation:
Brito L, Wilton J, Ferrándiz MJ,
Gómez-Sanz A, de la Campa AG
and Amblar M (2017) Absence
of tmRNA Has a Protective Effect
against Fluoroquinolones
in Streptococcus pneumoniae.
Front. Microbiol. 7:2164.
doi: 10.3389/fmicb.2016.02164
Absence of tmRNA Has a Protective
Effect against Fluoroquinolones in
Streptococcus pneumoniae
Liliana Brito1, Joana Wilton1†, María J. Ferrándiz2, Alicia Gómez-Sanz1,
Adela G. de la Campa2,3* and Mónica Amblar1*
1 Unidad de Patología Molecular del Neumococo, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid,
Spain, 2 Unidad de Genética Bacteriana, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain,
3 Presidencia, Consejo Superior de Investigaciones Científicas, Madrid, Spain
The transfer messenger RNA (tmRNA), encoded by the ssrA gene, is a small non-
coding RNA involved in trans-translation that contributes to the recycling of ribosomes
stalled on aberrant mRNAs. In most bacteria, its inactivation has been related to a
decreased ability to respond to and recover from a variety of stress conditions. In this
report, we investigated the role of tmRNA in stress adaptation in the human pathogen
Streptococcus pneumoniae. We constructed a tmRNA deletion mutant and analyzed
its response to several lethal stresses. The 1ssrA strain grew slower than the wild type,
indicating that, although not essential, tmRNA is important for normal pneumococcal
growth. Moreover, deletion of tmRNA increased susceptibility to UV irradiation, to
exogenous hydrogen peroxide and to antibiotics that inhibit protein synthesis and
transcription. However, the 1ssrA strain was more resistant to fluoroquinolones,
showing twofold higher MIC values and up to 1000-fold higher survival rates than
the wild type. Deletion of SmpB, the other partner in trans-translation, also reduced
survival to levofloxacin in a similar extent. Accumulation of intracellular reactive oxygen
species associated to moxifloxacin and levofloxacin treatment was also highly reduced
(∼100-fold). Nevertheless, the 1ssrA strain showed higher intracellular accumulation of
ethidium bromide and levofloxacin than the wild type, suggesting that tmRNA deficiency
protects pneumococcal cells from fluoroquinolone-mediated killing. In fact, analysis of
chromosome integrity revealed that deletion of tmRNA prevented the fragmentation of
the chromosome associated to levofloxacin treatment. Moreover, such protective effect
appears to relay mainly on inhibition of protein synthesis, since a similar effect was
observed with antibiotics that inhibit that process. The emergence and spread of drug-
resistant pneumococci is a matter of concern and these results contribute to a better
comprehension of the mechanisms underlying fluoroquinolones action.
Keywords: Streptococcus pneumoniae, tmRNA, trans-translation, stress adaptation, antibiotic resistance,
fluoroquinolones, chromosomal fragmentation, reactive oxygen species
INTRODUCTION
The transfer messenger RNA (tmRNA) is a ubiquitous specialized small non-coding RNA
encoded by the ssrA gene that functions as both a tRNA and an mRNA. It works together
with the SmpB protein in the trans-translation system, a quality control pathway that
rescues ribosomes stalled on non-stop mRNAs (Keiler et al., 1996; Karzai et al., 1999, 2000).
During trans-translation, the tmRNA-SmpB complex shifts the translation of the nascent
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peptide from the aberrant mRNA to the tmRNA-coding
sequence, allowing resumption of translation while targeting the
peptide for degradation and recycling ribosomes (Giudice et al.,
2014; Shimizu, 2014). Accumulation of stalled ribosomes is toxic
and they need to be rescued, otherwise, the cell would rapidly be
depleted of translational ribosomes and protein synthesis would
come to halt. Some bacteria have alternative backup systems that
use either ArfA or ArfB factors to recognize no-stop complexes,
promote hydrolysis of the peptidyl-tRNA and release the stalled
ribosome (Chadani et al., 2010, 2011; Schaub et al., 2012; Keiler
and Feaga, 2014). Impairment of trans-translation leads to a wide
variety of phenotypes, likely influenced by the status of ArfA
and/or ArfB. These phenotypes range from very subtle growth
defects to lethality, but the most common are associated to defects
in pathogenicity and stress-adaptation (Oh and Apirion, 1991;
Komine et al., 1994; Julio et al., 2000; Muto et al., 2000; Okan
et al., 2006; Li et al., 2008; Barends et al., 2010; Nichols et al.,
2011; Mann et al., 2012; Svetlanov et al., 2012; Mu et al., 2013),
or to increased sensitivity to antibiotics targeting translation (de
la Cruz and Vioque, 2001; Abo et al., 2002; Vioque and de la Cruz,
2003; Luidalepp et al., 2005; Okan et al., 2006; Nichols et al., 2011;
Svetlanov et al., 2012). In addition to quality control pathways,
some genetic regulatory circuits use trans-translation to control
gene expression, and diverse bacteria require trans-translation
when they execute large changes in their genetic programs (Abo
et al., 2000; Christensen and Gerdes, 2003; Christensen et al.,
2003; Keiler and Shapiro, 2003; Ranquet and Gottesman, 2007;
Keiler, 2008; Kobayashi et al., 2008). Therefore, the contribution
of tmRNA and the trans-translation mechanism to cell survival
differs among bacteria, and key questions regarding their utility
remain unanswered.
We wanted to investigate the role of the tmRNA in the
human pathogen Streptococcus pneumoniae. This bacterium is
responsible for a wide spectrum of human diseases, ranging
from mild otitis media to more severe infections such as
meningitis, sepsis, or endocarditis (WHO, 2007)1. It is the most
common bacterial cause of community-acquired pneumonia
and the leading cause of vaccine-preventable deaths in children
<5 years old (O’Brien et al., 2009). Treatment of pneumococcal
diseases is hampered by the emergence and spread of drug-
resistant strains to traditionally effective agents, including beta-
lactam antibiotics (Jacobs et al., 2003) and macrolides (Sahm
et al., 2001). Fluoroquinolones (FQs), such as levofloxacin
(LVX) and moxifloxacin (MOX), are currently used for the
treatment of pneumococcal pneumonia in adult patients. These
antibiotics inhibit type II DNA topoisomerases, ubiquitous
enzymes that manage DNA topology and solve topological
problems associated with DNA replication, transcription, and
recombination (Champoux, 2001). It has been proposed that
several FQs require ongoing protein synthesis to cause cell
death, and that protein synthesis inhibitors may protect from
chromosome fragmentation (Chen et al., 1996; Malik et al.,
2006, 2007). In addition, reactive oxygen species (ROS) such
as superoxide, hydrogen peroxide (H2O2) and hydroxyl radical,
contribute to FQ-mediated killing (Dwyer et al., 2007, 2014;
1http://www.who.int
Kohanski et al., 2007; Wang and Zhao, 2009; Wang et al.,
2010). In S. pneumoniae, the mechanisms leading to ROS
accumulation mediated by LVX and MOX have been recently
elucidated (Ferrándiz and de la Campa, 2014; Ferrándiz et al.,
2016). Both FQs induce global transcriptional responses that,
although through different pathways, ultimately stimulate the
Fenton reaction, increasing ROS accumulation and contributing
to cell death.
Expression of tmRNA in the pneumococcus was recently
demonstrated (Kumar et al., 2010; Acebo et al., 2012; Mann
et al., 2012; Wilton et al., 2015) and, although no functional
studies have been reported so far, its deficiency has strong
effects in pathogenesis. In fact, ssrA inactivation reduced the
ability to adhere and to invade endothelial cells, reduced the
fitness and competitive index in lungs and causes attenuation in
invasive diseases upon intranasal challenge (Mann et al., 2012).
Regarding SmpB, its partner in trans-translation, it has been
demonstrated that expression of the pneumococcal SmpB protein
is induced under cold-shock and that its levels are regulated
by RNase R, an exoribonuclease involved in degradation of
faulty mRNAs released from stalled ribosomes during trans-
translation (Richards et al., 2006; Moreira et al., 2012). However,
a direct link between trans-translation and survival to stress or
antibiotic susceptibility/resistance, have never been established in
S. pneumoniae.
The aim of the present study was to investigate the role
of tmRNA in adaptation of S. pneumoniae to environmental
conditions and antibiotic stress. We examined how the absence
of tmRNA affects survival to several lethal environmental
conditions and the activity of chemically unrelated antibiotics,
some of which are commonly used in clinical practice. We
showed that tmRNA deficiency had a detrimental effect on
growth and was more sensitive to UV, H2O2 and to a
variety of antibiotics. However, deletion of tmRNA highly
increased bacterial survival against FQs, decreased accumulation
of intracellular ROS and reduced chromosomal fragmentation.
This is the first study reporting a higher FQ-resistance phenotype
associated to tmRNA deficiency, which has been generally
considered as a stress-adaptation RNA.
MATERIALS AND METHODS
Bacterial Strains, Plasmids, Growth
Conditions, and Transformation
Streptococcus pneumoniae strains and plasmids used in this
study are described in Table 1. Pneumococci were grown as
static cultures either in Todd-Hewitt medium supplemented
with 0.5% of yeast extract (THY), or in a casein hydrolase-
based medium (AGCH) supplemented with 0.3% sucrose and
0.2% of yeast extract (A+SY). All constructs and cloning
experiments were carried out in the pneumococcal R6 strain.
TIGR4 cells were transformed as previously described (Acebo
et al., 2012) and plated onto blood agar plates. R6 cells were
transformed as described previously (Lacks et al., 1986) and
transformants were plated on A+SY media plates containing
1% agar. Incubations were performed at 37◦C in a 5% CO2
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TABLE 1 | Bacterial strains and plasmids used in this study.
Bacterial strain Description Source
TIGR4 Capsular type 4 clinical isolate
strain TIGR4
Tettelin et al., 2001
TIGR41ssrA TIGR4 ssrA::Kmr This study
TIGR41smpB TIGR4 smpB::Kmr Moreira et al., 2012
R6 Non-encapsulated strain derived
from the capsular type 2 clinical
isolate strain D39
Laboratory collection
R61ssrA R6 ssrA::Kmr This study
R61ssrA(ROM) R61ssrA [pROM] This study
R61ssrA(ssrA+) R61ssrA [pROM-TM] This study
Plasmids
pLS1ROM Ruiz-Masó et al., 2012
pROM pLS1ROM lacking PM promoter This study
pROM-TM pROM containing tmRNA
chromosomal fragment
This study
atmosphere. The pROM plasmid was constructed by deleting
the 173 bp fragment containing the maltose-inducible promoter
(PM) of pLS1ROM (Ruiz-Masó et al., 2012). For this purpose,
the whole plasmid (excluding PM) was amplified through
reverse PCR using pROM-F-Xba2 and pROM-R-Xba2 primers
(Table 2). The fragment was then digested with XbaI and
further ligated to obtain pROM. The pROM-TM plasmid was
obtained by cloning a 531 bp chromosomal region containing
the entire tmRNA encoding gene ssrA gene (including its own
promoter) into pROM. This fragment was amplified by PCR from
TIGR4 chromosomal DNA using Expand High Fidelity (Roche).
Primers used were tmRNACj-F and tmRNACj-R (Table 2), which
contained the BamHI and HindIII restriction sites, respectively.
The PCR product was cloned into pROM vector making use
of the BamHI and HindIII restriction sites, thus obtaining
the pROM-TM plasmid, which was then transformed into R6
competent cells. Transformants were selected using 1 µg/ml
of erythromycin and cloning was verified by DNA sequencing.
Expression of tmRNA in trans was confirmed by Northern-blot
as previously described (Acebo et al., 2012).
Construction of Genetically Modified
Strains
The TIGR4 tmRNA deletion mutant (TIGR41ssrA) was
constructed by insertion-deletion of a kanamycin resistance
cassette (Kmr) through allelic replacement mutagenesis (Song
et al., 2005). For this purpose, three fragments were generated
by PCR. Two of them contained the upstream and downstream
tmRNA regions and were obtained using oligonucleotide pairs
tmRNA-F/tmRNAKmUp-R and tmRNAKmDown-F/tmRNA-R,
respectively (Table 2). The third fragment, containing Kmr,
was amplified from pR410 plasmid (Sung et al., 2001) using
KmN-F and KmN-R primers (Table 2). Primers tmRNAKmUp-
R and tmRNAKmDown-F partially overlapped with KmN-F and
KmN-R, respectively, to allow further hybridization of up- and
downstream fragments with the amplified Kmr fragment. The
three resulting PCR products were purified, mixed together,
amplified using tmRNA-F and tmRNA-R primers, and used
to transform strain TIGR4 (Figure 1A). Construction of the
R6 tmRNA deletion strain (R61ssrA) was performed through
amplification of a 3744 bp fragment encompassing tmRNA
insertion/deletion from TIGR41ssrA chromosomal DNA using
tmRNA-1 and tmRNA-2 primers (Table 2) and further
transformation of R6. In both cases, transformants were selected
with 250 µg/ml of Km, and confirmed by PCR amplification
with external oligonucleotides tmRNA-1 and tmRNA-2 and DNA
sequencing.
Hydrogen Peroxidase and Paraquat
Sensitivity Assays
Hydrogen peroxidase sensitivity assays were performed
essentially as described by Pericone et al. (2003). Briefly, bacteria
were grown in THY broth until an absorbance at 600 nm (A600)
of 0.2 and diluted twofold in the same medium containing
40 mM H2O2 (Sigma-Aldrich), resulting in an true exposure
of 20 mM H2O2. Bacteria were incubated at 37◦C for 30 min
and reactions were stopped by adding 200 U of bovine liver
catalase (Sigma-Aldrich). Serial dilutions were plated in blood
agar plates and incubated overnight at 37◦C in a 5% CO2
TABLE 2 | List of primers used in this study.
Primer Nucleotide sequence 5′–3′ Description
tmRNA-F TTCTGTGTCAGGGTAAGTTCC Up PCR fragment for 1ssrA construction
tmRNAKmUp-R TTATCCATTAAAAATCAAACGGATCACATACCTAAGATGAAGCTATCT
tmRNA-R ACTGAATCACCTCCTGTTATCG Down PCR fragment for 1ssrA construction
tmRNAKmDown-F TACGAGGAATTTGTATCGATGTGGACGTGGGTTCGACT
KmN-F CCGTTTGATTTTTAATGGATAA Kmr cassette for 1ssrA construction
KmN-R CATCGATACAAATTCCTCGTA
pLSROM-F-Xba2 CGTCTGCAAAATACTCTAGAGATGGATCAAG For pROM construction
pLSROM-R-Xba2 CTCACGAGACAGTCTAGAAAGTACAAAACCTCC
tmRNACj-F CGCGGATCCTTCATCTTAGGTATGTGATTTC For ssrA cloning
tmRNACj-R GCGCAAGCTTGGTCTGTTTGTGACTCCC
tmRNA-1 AATTATCCTGCGCTCCAGAA For 1ssrA construction and DNA sequencing
tmRNA-2 TTTCAAGACACGGCTGACA
Underlined sequence indicates enzyme restriction sites.
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FIGURE 1 | Transfer messenger RNA (tmRNA) deficiency is detrimental under certain stress conditions. (A) Inactivation of ssrA gene (black) by
insertion/deletion of Kmr (light gray). Flanking ORFs (white) and tRNA gene (dark gray) are depicted. Promoters (curved arrows), terminators (stem-loop structures)
and primers used (black arrows) are shown (B) Growth curves of wild type TIGR4 (wt) strain and its tmRNA deletion mutant (1ssrA) in THY broth at 37◦C.
(C) Survival of wt and 1ssrA upon treatment with 30 mM paraquat at the indicated times, after UV irradiation at the intensities indicated, or after 30 min of exposure
to 20 mM of hydrogen peroxide. Survival was determined as described in Section “Materials and Methods.” Values (mean ± SD) are the average of at least three
independent experiments and the means were statistically compared using Student’s t-test (∗P < 0.05; ∗∗P < 0.01).
atmosphere. Percentage of survival cells was calculated relative
to the untreated control bacteria. Paraquat sensitivity assays
were performed as previously described (Andisi et al., 2012).
Bacteria were grown until A600 = 0.2, and diluted twofold in the
same medium with 30 mM paraquat (Sigma-Aldrich) or without
paraquat, and incubated at 37◦C for 2-h. Samples were taken at
time intervals and the number of viable cells was determined by
plating onto blood agar plates.
Susceptibility to UV Irradiation Assays
Susceptibility to UV irradiation assays were performed as
previously described (Halpern et al., 2004). Cells were grown in
A+SY medium to exponential phase (an A620 of approximately
0.2). Serial dilutions were then plated and exposed to UV light
at 254 nm at the indicated intensities. Percentage of survival
was estimated by colony counting relative to untreated control
samples.
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Antibiotic Susceptibility Studies and
Detection of Reactive Oxygen Species
MICs were determined by the broth macrodilution method
(Clinical and Laboratory Standards Institute, 2008). To measure
lethal action of antibiotics, pneumococci were grown in A+SY
medium to A620 = 0.4, diluted 100-fold and treated with the
antibiotic. Samples were withdrawn at time intervals and colony
formation was determined by plating on drug-free blood agar
plates. The percentage of surviving cells was calculated relative
to untreated control samples. When indicated, 10 µg/ml of
chloramphenicol or 0.3 µg/ml of erythromycin was added to the
culture 10 min prior to FQ addition and maintained throughout
treatment. Intracellular oxidation level upon FQ treatment was
measured by ROS detection using dihydrorhodamine 123 dye
(Sigma-Aldrich) as previously described (Ferrándiz and de la
Campa, 2014). Results were expressed as relative fluorescence
units (RFU) and were made relative to time point zero, and
normalized according to the number of live cells at each time
point.
Ethidium Bromide Uptake and Efflux
Studies
Uptake of ethidium bromide (EtBr) was measured by
fluorescence spectrophotometry as previously described (Pérez-
Boto et al., 2015) with several modifications. Bacteria were grown
at 37◦C to mid-logarithmic phase (A620 = 0.4) in A+SY medium.
Cells were harvested, washed and suspended in phosphate saline
buffer (PBS) (pH 7.2) with 0.2% glucose to A620 = 0.2. After
10 min of incubation at 37◦C, bacteria were exposed to 2 µg/ml
of EtBr, with or without 20 µg/ml reserpine. Increase of
fluorescence as EtBr entered the cells was directly recorded along
20 min, measuring every 0.25 s at 530 nm (excitation wavelength)
and 600 nm (emission wavelength) in a Varian Cary Eclipse
Spectrophotometer (Agilent Technologies Spain S. L. Madrid,
Spain). The mean of at least three independent experiments was
obtained.
Measurement of EtBr eﬄux was based on previously described
method (Jumbe et al., 2006). Bacterial suspensions at A620 = 0.2
were prepared in PBS with 0.2% glucose as described above.
Bacteria were then exposed to EtBr for 20 min at 37◦C in the
presence of reserpine to maximize EtBr loading into bacteria.
Cells were collected by centrifugation and suspended in fresh
PBS + 0.2% glucose. Eﬄux of EtBr from cells was measured as
fluorescence signal decrease during 20 min.
FQ Accumulation Measurements
Accumulation of LVX on each strain was measured by
fluorescence essentially as previously described (Piddock and
Johnson, 2002). A starter culture was diluted 40-fold in 100 ml
of A+SY medium, and grown at 37◦C to A620 = 0.5. Cells were
washed and concentrated 20-fold in 0.1 M sodium phosphate
pH 7.0, and the suspension was equilibrated for 10 min at
37◦C prior to accumulation measurements. LVX was added at
different concentrations and suspensions were incubated at 37◦C
for the indicated times. 0.5 ml aliquots were withdrawn and
added to 2.5 ml of ice-cold 0.1 M sodium phosphate, washed
with the same buffer and resuspended in 0.1 M glycine pH
3 to achieve cell lysis. After incubating at room temperature
overnight, samples were centrifuged twice at 10000 × g for
10 min. LVX concentration in the supernatant was measured
by fluorescence spectroscopy at 295 nm (excitation wavelength)
and 496 nm (emission wavelength), and compared to a standard
fluorescence curve previously obtained. Accumulation data were
converted into µg of LVX per ml.
Analysis of Chromosome Fragmentation
by PFGE
Chromosomal fragmentation was detected by pulsed-field gel
electrophoresis (PFGE) as previously described (Ferrándiz et al.,
2016). A starter culture was diluted 40-fold in A+SY medium
and grown at 37◦C to A620 = 0.3. Bacteria were then treated
with 10× MIC of LVX and incubated at 37◦C for an additional
30 min. Cells were harvested, washed twice with wash buffer
(1 M NaCl, 10 mM Tris pH 8) and inserted in solid agarose
blocks for further lysis as described previously (Ferrándiz et al.,
2016). Electrophoresis was performed in a Cheff-DR III system
(Bio-Rad), for 20 h at 5.8 V/cm with a 0.1- to 40-s switch-time
ramp at 14◦C. Gels were stained with 0.5 µg/ml EtBr for 1 h
and further distained in water during the same time. Percentages
of chromosomal fragmentation were estimated by quantification
of relative band intensities in each lane, corresponding to
fragmented (compression zone) and non-fragmented (retained in
the well) DNA.
RESULTS
Deficiency of tmRNA Reduces Bacterial
Growth and Increases Sensitivity to
Stress
Transfer messenger RNA is a major actor in the trans-
translation mechanism and, although its contribution to cell
survival differs among bacteria, its inactivation is expected
to diminish recovery from stress. To investigate the role of
tmRNA in S. pneumoniae we constructed a TIGR4 tmRNA
mutant (TIGR41ssrA) by deletion of its ssrA encoding gene
and insertion of Kmr (Figure 1A). Deletion of ssrA increased
the doubling time at 37◦C from 42.8 ± 1.9 min (mean ± SD)
to ∼61.7 ± 2.4 min (Table 3). These results indicated that,
although tmRNA is not essential for the pneumococcus, its
absence has a detrimental effect on growth (Figure 1B). We
next evaluated the sensitivity to various environmental stress
conditions. TIGR41ssrA was 3- to 4-fold more susceptible
than TIGR4 to 30 mM paraquat, which induces formation
of superoxide inside the cell (Figure 1C). However, these
differences, although evident, were not statistically significant
(P= 0.055 after 60 min and P= 0.092 after 120 min). By contrast,
TIGR41ssrAwas significantly more susceptible to treatment with
UV light at 254 nm, with survival rates 2.5-fold (at 10 J × m−2;
P = 0.015) and threefold (at 20 J × m−2; P = 0.0027) lower
than TIGR4 (Figure 1C). Moreover, addition of exogenous H2O2
was highly deleterious for TIGR41ssrA, whose survival was
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TABLE 3 | Doubling time of pneumococcal strains used.
Strain Duplication time (min)1
37◦C 30◦C
TIGR4 42.8 ± 1.9 n.d.
TIGR41ssrA 61.7 ± 2.4 n.d.
R6 48.6 ± 0.9 65.4 ± 1.0
R61ssrA 62.2 ± 2.2 95.7 ± 4.5
R61ssrA(ROM) 85.4 ± 5.6 108.1 ± 10.1
R61ssrA(ssrA+) 41.0 ± 2.4 68.6 ± 1.5
1Values were calculated from growth curves performed in A+SY medium at 37
or 30◦C in a TECAN infinite F200 plate reader and are the average ± standard
deviation of, at least, three independent experiments. n.d., not determined.
TABLE 4 | In vitro antibiotic susceptibilities determined by macrodilution in
TIGR4 and R6 strains of Streptococcus pneumoniae.
Drug MIC µg/mL1 Fold
change2
TIGR4 TIGR41ssrA R6 R61ssrA
Chloramphenicol 1 0.5 n.d. n.d. 2 ↓
Tetracycline 0.125 0.062 n.d. n.d. 2 ↓
Erythromycin 0.03 0.0075 n.d. n.d. 4 ↓
Rifampicin 0.06 0.03 n.d. n.d. 2 ↓
Penicillin 0.016 0.016 n.d. n.d.
Cefotaxime 0.015 0.015 n.d. n.d.
Moxifloxacin 0.25 0.50 0.125 0.25 2 ↑
Levofloxacin 0.50 1 0.25 0.50 2 ↑
Ciprofloxacin n.d. n.d. 0.50 1 2 ↑
Norfloxacin n.d. n.d. 4 8 2 ↑
1Results are the average of at least three independent replicates. n.d., not
determined. 2Fold change denotes the ration between the values for the wild type
strains and their corresponding 1ssrA derivative.
reduced∼400-fold after 30 min of incubation with 20 mM H2O2
(P = 0.005) (Figure 1C). These results revealed the importance
of tmRNA and the trans-translation mechanism in adaptation of
S. pneumoniae to certain environmental stress conditions.
We then examined the effect of the ssrA deletion under
antimicrobial stress and determined the MIC values of several
drugs from different families (Table 4). Deletion of ssrA
lowered the MICs of antibiotics targeting translation, such as
chloramphenicol (CM), erythromycin (EM) and tetracycline,
and transcription, such as rifampicin, 2- or 4-fold, but had no
effect with beta-lactams such as penicillin or cefotaxime, which
interfere with cell wall synthesis. However, the MICs of MOX
and LVX were higher for the 1ssrA strain than for the wild type
by 1 dilution factor (Table 4). Such difference, although low,
suggested that the tmRNA deletion reduces susceptibility to these
drugs.
Absence of tmRNA Increases Resistance
to FQs and Reduces ROS Production
To confirm the apparent lower susceptibility of 1ssrA and better
understand the effect of tmRNA on FQ activity, we determined
the survival of wild type and mutant strains upon treatment
with different concentrations of LVX and MOX from 1 to
4 h. The TIGR41ssrA was much more resistant to killing by
both FQs at all times and concentrations tested, showing up
to ∼150- (for LVX) and ∼100-fold (for MOX) higher survival
rates than the wild type (Figure 2A). This effect was specific
to FQs as no differences in survival were observed with the
other bactericidal agent penicillin (Figure 2A). Moreover, this
phenotype was associated to defects in trans-translation since
similar survival rates to 5× MIC of LVX were observed with
the 1smpB mutant lacking SmpB, the other indispensable
partner for trans-translation (Figure 2A). Provided that FQ
lethality is associated to ROS production we determined the
internal levels of ROS in TIGR4 and TIGR41ssrA upon LVX
and MOX treatment at the same time points and antibiotic
concentrations. ROS accumulation in TIGR41ssrA was highly
reduced compared to TIGR4, showing a decrease of more than
∼120-fold after 2 h treatment with both antibiotics (Figure 2B).
These results demonstrated that the higher survival rate exhibited
by TIGR41ssrA is related with a reduction in ROS production.
To ensure that the less FQ-sensitive phenotype of the tmRNA
deficiency was not related with the genetic background, a
similar analysis was performed using strain R6. We constructed
the R61ssrA strain and analyzed growth under different
concentrations of LVX. As shown in Figure 3A, growth inhibition
upon antibiotic treatment was lower in R61ssrA than in R6,
and the differences between strains increased proportionally with
LVX concentration up to 1 µg/ml. The study was extended to
other FQs and the MIC values of LVX, MOX, ciprofloxacin
(CPX), and norfloxacin (NFX) were determined. In all cases, the
MICs were higher for R61ssrA than for R6 (Table 4), confirming
less susceptibility to all FQs. We then compared survival of R6
and R61ssrA strains upon treatment with the four distinct FQs
(Figure 3B). As in the TIGR4 genetic background, the lethal
action of the four FQs was reduced several 100-fold in the
R61ssrA, and this effect was associated with >2-log decrease
in ROS accumulation after LVX treatment (Figure 3C). To
attribute protection from FQ lethal activity to tmRNA deficiency,
complementation experiments were performed. The pROM-TM
plasmid containing the entire ssrA gene was constructed and
introduced into R61ssrA. Expression of tmRNA in trans in this
strain was confirmed by Northern blot-analysis (Figure 3D).
Survival during LVX treatment revealed that the complemented
strain was killed to the same extent as R6, while R61ssrA with
the empty vector did not (Figure 3B). Furthermore, since the
potency of bactericidal compounds may increase with faster
bacterial growth rate (Deitz et al., 1966), the possibility exists
that the higher survival to FQs shown by R61ssrA resulted
from its slower growth. To exclude this possibility, we analyzed
survival of R6 to LVX at 30◦C, which reduced the doubling
time of wild type cells (65.4 ± 1.0 min) to the same levels
as the R61ssrA mutant at 37◦C (62.2 ± 2.2 min) (Table 3).
Results showed that resistance to LVX of R6 indeed partially
increased at 30◦C, showing 7.7- and 8.4-fold higher percentages
of survival than at 37◦C after 3 and 4 h treatment, respectively
(Figure 3B). However, these values were far from those obtained
with R61ssrA at 37◦C, which showed survival percentages of
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FIGURE 2 | Deletion of tmRNA reduces lethality of FQs but not of penicillin. (A) Percentage of survival of wt, 1ssrA and TIGR41smpB (1smpB ) strains upon
treatment with LVX, MOX and/or penicillin (PEN). Exponentially growing cells were treated with each antibiotic at the concentration and times indicated. Survival was
determined as described in Section “Materials and Methods.” (B) Accumulation of ROS in wt and 1ssrA strains upon treatment with 2.5 and 5× MIC of LVX and
MOX were measured in the same samples as described in Section “Materials and Methods.” RFU, relative fluorescence units; fluorescence units were divided by the
number of viable cells and normalized to time zero and no antibiotic treatment condition. Values (mean ± SD) of at least three independent experiments are shown.
The MIC values used were those determined in Table 4.
about 1100- and 450-fold higher after 3 and 4 h of LVX-treatment,
respectively.
From these experiments we can conclude that 1ssrA strain is
better able to survive to the lethal effect of FQs than ssrA+ cells
and that this phenotype does not relay only in growth defect, but
in another mechanism of protection directly linked with defects
in trans-translation.
tmRNA Deficiency Increases FQ
Accumulation
The less sensitive phenotype of the tmRNA deletion mutant could
be due to a lesser accumulation of FQs inside the cell, due to
changes in membrane permeability. To explore this possibility,
we conducted experiments comparing EtBr uptake and eﬄux
in both R6 and R61ssrA strains. Results revealed that EtBr
uptake was higher in R61ssrA than in R6 and, simultaneously,
the eﬄux was lower (Figure 4A). As a consequence, internal
levels of EtBr in R61ssrA were higher than in R6. Addition of
reserpine, an eﬄux pump inhibitor in streptococci (Ferrándiz
et al., 1999; Piddock and Johnson, 2002), considerably increased
EtBr accumulation in the wild type strain, while the effect in
R61ssrA was much lower. Remarkably, EtBr levels accumulated
in R6 upon reserpine addition were equivalent to the levels
in R61ssrA without the inhibitor. These results indicate that
the eﬄux pumps in R61ssrA are less active in exporting EtBr,
leading to higher accumulation of this drug. We analyzed
whether the observed effect was specific to EtBr or whether
the accumulation of LVX was also increased in the 1ssrA
mutant. We examined levels of intracellular LVX upon treatment
with different antibiotic concentrations and different exposure
times. Again, R61ssrA accumulated higher amounts of LVX
than R6 in all cases (Figure 4B). These results suggest that the
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FIGURE 3 | Transfer messenger RNA deficiency protects from FQs lethal action. (A) Wild type R6 strain (wt) and its tmRNA deletion mutant (1ssrA) were
grown under different LVX concentrations in A+Y medium. Growth was followed by turbidity (OD620 nm) in a TECAN infinite F200 plate reader at 37◦C.
(B) Percentage of survival to different FQs of wt, 1ssrA, the complemented strain containing the pROM-TM (1ssrA(ssrA+)) and the 1ssrA containing the empty
vector (ROM) at 37◦C, and of wt at 30◦C. Exponentially growing cells were treated with 5× MIC (as determined in Table 4) of LVX, ciprofloxacin (CPX), norfloxacin
(NFX), or MOX for the times indicated. After incubation, survival was determined as described in Section “Materials and Methods.” (C) Accumulation of ROS in wt
and 1ssrA upon addition of 5× MIC of LVX was measured as described in Section “Materials and Methods.” RFU; fluorescence units were divided by the number of
viable cells and normalized to time zero and no antibiotic treatment condition. (D) Northern-blot showing tmRNA expression in wt, 1ssrA and 1ssrA(ssrA+). Bands
corresponding to tmRNA and the control 5S rRNA are indicated by arrows. Northern-blots were performed as described (Acebo et al., 2012). Values (mean ± SD) of
at least three independent experiments are shown. MIC values were determined in Table 4.
absence of tmRNA indeed induces changes in S. pneumoniae
membrane permeability. However, instead of reducing levels of
EtBr and LVX inside the cell, these changes lead to their higher
accumulation.
Absence of tmRNA Protects from
Chromosomal Fragmentation Associated
to FQs
Since the lethal effect of FQs has been correlated with
chromosome fragmentation, we examined LVX-associated DNA
breakage in R6 and R61ssrA after 30 min of exposure to 10×
MIC of LVX (Figure 5). Percentage of the bands corresponding
to the compression zone (CZ, containing the large size
nicked fragments of chromosomal DNA) was used to estimate
chromosomal fragmentation. As shown in Figures 5A,B, LVX
treatment induced a 16.7 ± 1.6% (mean ± SD) fragmentation
in R6, compared with the 6.5 ± 1.9% observed without
the antibiotic. However, such increase was not observed in
R61ssrA, whose fragmentation levels with and without LVX
were similar (7.1 ± 1.25 and 6.7 ± 2.6%, respectively).
Interestingly, overexpression of tmRNA in the complemented
strain completely restored the initial levels of fragmentation to
16.5 ± 2.7%, while the empty vector did not (8.8 ± 2.2%).
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FIGURE 4 | Transfer messenger RNA deficiency leads to higher
intracellular accumulation of drugs. (A) EtBr uptake (left panel) and efflux
(right panel) of R6 (wt) and R61ssrA (1ssrA) strains during 20 min was
measured as described in Section “Materials and Methods.” Fluorescence
intensity represents levels of intracellular EtBr. The change in fluorescence is
normalized to the initial levels to allow for direct comparison. Fluorescence
was directly recorded during 20 min after addition of EtBr in the presence
(+Res) or in the absence of reserpine. (B) Fluorometric measurement of
intracellular accumulation of levofloxacin (LVX) in wt and 1ssrA at different LVX
concentrations (left panel) and time points (right panel), as described in
Section “Materials and Methods.” Three to five independent experiments were
conducted and the mean values were statistically compared using Student’s
t-test (∗P < 0.05).
Therefore, we can conclude that the absence of tmRNA
protects from chromosome fragmentation associated to FQs
treatment.
Absence of tmRNA is expected to slow down translation due
to lack of turnover of stalled ribosomes and it is known that
in Escherichia coli several FQs require active protein synthesis
to cause cell death (Malik et al., 2006, 2007). Therefore, it is
possible that the protective effect of 1ssrA could be related
to a lower protein synthesis rate. To explore this possibility,
we tested the effect of the protein inhibitor CM as a blocking
agent of FQ-lethal action in the pneumococcus. For this purpose,
bacterial cultures were treated with 10× MIC of CM for
10 min, and then different concentrations of LVX were added
for 1 additional hour. As shown in Figure 5C, incubation with
CM drastically reduced cell death in R6, increasing survival
from ∼0.1% in the absence of the protein inhibitor, to values
ranging between 25 and 60%. Similar percentages of survival
were observed in R61ssrA when treated with CM, in which
cell death levels without protein inhibitor treatment were
also remarkably higher (5–10%) than in the wild type. The
protective effect of CM increased at longer times and it was
extended to other protein inhibitors such as EM. Incubation with
both antibiotics increased survival to LVX after 2 h-treatment
more than 200-fold (Figure 5D). This means that LVX lethal
action in S. pneumoniae also requires active protein synthesis,
what could explain the less susceptible phenotype of 1ssrA
cells.
DISCUSSION
In this study we provide evidence that S. pneumoniae relies
on tmRNA for adaptation to a variety of environmental
conditions, and that its inactivation reduces the ability of the
pneumococcus to cope with several stresses. Our findings showed
that tmRNA is not essential for growth in the pneumococcus,
although its absence significantly reduced growth rate. Most
bacteria require a system to resolve non-stop complexes (Keiler
and Feaga, 2014). On this regard, S. pneumoniae is not an
exception. The presence of a putative ArfB encoding gene
has been predicted in the pneumococcal genome (Keiler and
Feaga, 2014) and this is probably the reason why tmRNA
is not essential for growth. Moreover, we demonstrated that
insertional inactivation of tmRNA did not affect survival to
internal oxidative stress induced by paraquat, but reduced the
ability to survive to the lethal effect of UV irradiation and
had a deleterious effect upon exposure to exogenous H2O2.
We also demonstrated that pneumococcal cells lacking tmRNA
exhibited higher susceptibility to antibiotics that inhibit protein
synthesis or transcription, but not to those targeting cell wall
synthesis. The increased sensitivity to protein synthesis inhibitors
was rather moderate, similarly to what was previously observed
for E. coli (Abo et al., 2002), Synechocystis (de la Cruz and
Vioque, 2001) or Francisella tularensis (Svetlanov et al., 2012),
whose ssrA null mutants were more sensitive to sublethal
concentrations of these drugs. Inhibition of the translation
elongation process may cause ribosome stalling, translational
inaccuracy and/or read-through, leading to the accumulation of
non-stop complexes (Thompson et al., 2002, 2004; Vioque and
de la Cruz, 2003). Therefore, the trans-translation system confers
the cells with partial resistance to certain antibiotics by dealing
with ribosome pausing. In case of rifampicin, the increment in
sensitivity exhibited by the 1ssrA mutant was also moderate.
A similar sensitive phenotype was observed in F. tularensis
(Svetlanov et al., 2012) but no in E. coli or Synechocystis (de
la Cruz and Vioque, 2001; Abo et al., 2002), suggesting certain
differences among bacteria. This antibiotic inhibits transcription
and no ribosome stalling is expected upon rifampicin treatment.
However, translation and transcription are known to be coupled
and defects in RNA synthesis may ultimately have consequences
in translation.
Remarkably, our findings demonstrated that pneumococcal
cells lacking tmRNA were more resistant to the four FQs
tested (LVX, MOX, CPX, and NFX), showing both higher
MIC values (twofold) and higher survival rates (up to 1100-
fold). Such resistant phenotype was not observed with penicillin
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FIGURE 5 | Deficiency of tmRNA protects from chromosome fragmentation mediated by LVX. (A) Analysis of chromosome fragmentation upon LVX
treatment by PFGE. Exponentially growing cultures of R6 (wt), the R61ssrA (1ssrA) mutant, the complemented strain containing the pROM-TM (1ssrA(ssrA+)) and
the R61ssrA containing the empty vector (ROM), were treated with or without 10× MIC of LVX for 30 min and analyzed by PFGE as described in Section “Materials
and Methods.” (B) Chromosomal fragmentation was estimated by quantification of the compression zone (CZ) relative to the intact chromosomal DNA retained in the
well. Each value is the mean of at least three independent experiments and the mean values were statistically compared using Student’s t-test (∗∗P < 0.01).
(C) Percentage of survival to 1 h treatment of LVX at 5, 10, or 20× MIC of wt, 1ssrA strains previously incubated with 10 µ/ml of Chloramphenicol (CM) for 10 min. St
stands for the MidRange PFG Marker (Biolabs) with size ranges from 15 to 300 Kb. (D) Percentage of survival along the time to treatment with 5× MIC of wt strains
previously incubated with 10 µ/ml of CM or 0.3 µ/ml of erythromycin (EM) for 10 min. Survival was determined as described in Section “Materials and Methods.”
and was not due to the lower growth rate shown by the
tmRNA deletion mutant, since increasing the doubling time
of wild type at 30◦C had no the same effect. Moreover, this
protective phenotype was associated to trans-translation defects
and not to side effects of the tmRNA, since similar survival
rates were observed in a 1smpB strain. This is the first
study reporting a higher FQ-resistant phenotype associated to
tmRNA inactivation. These results contrast with those previously
obtained in E. coli or F. tularensis, where absence of tmRNA
was previously reported to either have no effect (Abo et al.,
2000; Luidalepp et al., 2005; Svetlanov et al., 2012) or to increase
sensitivity (Nichols et al., 2011; Li et al., 2013) to nalidixic acid,
ofloxacin, NFX or LVX. A possible explanation for the less
sensitive phenotype observed in S. pneumoniae could be that
depletion of tmRNA might influence membrane permeability,
leading to lesser accumulation of the drug inside 1ssrA cells.
In fact, absence of tmRNA is expected to prevents tmRNA-
mediated tagging of abnormal proteins for degradation and to
increases the levels of misfolded proteins (Gottesman et al., 1998;
Herman et al., 1998; Choy et al., 2007), whose insertion into
cell membrane could alter permeability. However, our results
demonstrated that cells lacking tmRNA accumulated more EtBr
Frontiers in Microbiology | www.frontiersin.org 10 January 2017 | Volume 7 | Article 2164
fmicb-07-02164 January 7, 2017 Time: 14:56 # 11
Brito et al. tmRNA Contributes to Fluoroquinolones Lethality
and LVX than the wild type cells. Therefore, cell membrane
integrity was indeed altered due to the deletion, but instead of
reducing drug accumulation, it led to a significant increase in the
levels of intracellular drugs. This means that tmRNA-depleted
cells are somehow protected from the lethal effects associated
to FQs.
ROS production contributes to FQ-lethality in S. pneumoniae.
The intervening pathways between LVX and MOX initial
antibiotic-target interaction and ROS formation are now known.
LVX treatment inhibits Topo IV increasing fatDCE operon
expression, what in turns, increases iron uptake (Ferrándiz and
de la Campa, 2014). In the case of MOX, inhibition of both
Topo IV and gyrase induce a transcriptomic response that
results in an intracellular pyruvate increment that consequently
leads to higher levels of H2O2 (Ferrándiz et al., 2016).
Consistently, our results demonstrated that the protective effect
against LVX and MOX of 1ssrA cells was accompanied by
a reduction in ROS accumulation. A similar protective effect
was also observed against NFX and CPX, both of which
target Topo IV (Muñoz and De La Campa, 1996), and whose
induction of intracellular ROS in S. pneumoniae has not been
determined. In E. coli, these FQs have been shown to act
through different pathways, and while NFX-mediated killing
involves ROS (Dwyer et al., 2007; Kohanski et al., 2007),
CPX is able to kill bacteria anaerobically (Malik et al., 2007).
Therefore, the protective effect of tmRNA absence may not be
related to specific pathways for each FQ, but to a common
feature to all of them. Nevertheless, since MOX addition in
pneumococcus triggered a threefold reduction in smpB transcript
levels (Ferrándiz et al., 2016), the involvement of tmRNA in
specific regulatory circuits contributing to FQ lethality cannot be
ruled out.
Independently of their target and mechanism of action,
FQs reversibly trap the topoisomerase on the chromosomal
DNA, in a ternary complex in which the DNA is broken
(Chen et al., 1996; Malik et al., 2006). Releasing of DNA
from these complexes generates deleterious double-stranded
breaks (Drlica et al., 2008). Therefore, no matter the pathway
used, the action of all FQs ultimately converges in lethal
chromosome fragmentation. On this regard, our findings
demonstrated that cells lacking tmRNA showed almost no
chromosome fragmentation after LVX treatment, and that the
sole tmRNA expression in trans is sufficient to completely
restore DNA fragmentation to wild type levels. We also
demonstrated that addition of CM or EM, which inhibit protein
synthesis, drastically increased survival of pneumococci exposed
to LVX. These findings confirm that LVX-mediated cell death in
pneumococcus also occurs via the protein synthesis-dependent
pathway and provide a possible explanation to the less susceptible
phenotype of 1ssrA cells. The absence of tmRNA is expected
to imperil translation due to accumulation of stalled ribosomes
in tmRNA depleted cells, which may give cells time to repair
damage.
CONCLUSION
Transfer messenger RNA has a protective effect under several
types of stresses in S. pneumoniae. Such protection is likely
due to its role in rescuing of stalled ribosomes, helping the
cell to recover and proceed with proper translation, and to
tagging of abnormal proteins for degradation. However, upon
FQ treatment, tmRNA is paradoxically harmful. The protective
effect against FQs associated to tmRNA deficiency is linked to
trans-translation and is due to the cumulative effect of two
processes: a reduction in ROS production and a decrease in
chromosome fragmentation, and translational pausing appear
to be the underlying mechanism. These findings should be
taking in consideration in the development of new antibiotics
inhibiting trans-translation. Its requirement for viability or
virulence in many pathogenic bacteria together with the low
expected toxicity in host cells due to its absence in metazoans,
has posed this pathway as an attractive antimicrobial target
(Keiler and Alumasa, 2013; Ramadoss et al., 2013; Keiler and
Feaga, 2014). However, our results evidence that inactivation of
trans-translation may have side effects leading to an undesirable
increase resistance to otherwise effective antibiotics. In addition,
although not currently used in clinical practice, our results
suggest that the combined use of FQs and antibiotics inhibiting
protein synthesis might not be recommended and evidence the
requirement of further studies on this matter.
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